Visioneering Technologies, Inc Appoints Dwight Akerman to Its Board of Directors, and as Chairman of the Science and Technology Committee of the Board
July 01, 2021 at 10:49 pm EDT
Share
Visioneering Technologies, Inc. announced the appointment of Dr. Dwight Akerman to its Board of Directors, and as Chairman of the Science and Technology Committee of the Board. Dr. Akerman is an optometrist and an experienced executive in the vision care industry, with 41 years of leadership in eye care, new product development, clinical and regulatory affairs, academic and professional affairs, business development and licensing, and executive management. He is currently the Chief Medical Editor of "Review of Myopia Management" and recently retired from Alcon as Vice President and Global Head of Professional Affairs and Business Development.
Visioneering Technologies, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture, sale and distribution of a contact lens, the NaturalVue Multifocal 1 Day (NaturalVue MF) contact lens. The Company operates through two segments: North America and Europe / Asia-Pacific. The North America segment includes its operations in the United States and Canada. The Europe/Asia-Pacific segment includes its operations outside of North America. Its flagship product is the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens for adults with Presbyopia and children with Myopia. The Company sells its contact lenses in the United States, Europe, Australia, New Zealand, Hong Kong, Singapore, Canada and Malaysia. The Company manages the warehousing and distribution of its products through a contract with a third-party logistics provider (the 3PL).
VISIONEERING TECHNOLOGIES, INC. 
